Iridex (IRIX) EBT Growth (3y) (2013 - 2026)
Powered by 
Analysis
Iridex (IRIX) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -2.34% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 28.31% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 13.94% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 20.27% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 35.51% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 23.63% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -30.37% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 25.85% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 17.92% |
| 10 | Iridex | 12.22 Mn | 7.54 Mn | 4.30 Mn | 24.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 4, 2026 | 24.29% |
| Apr 4, 2026 | 39.25% |
| Jan 3, 2026 | 11.32% |
| Sep 27, 2025 | 3.63% |
| Jun 28, 2025 | 24.09% |
| Mar 29, 2025 | 10.96% |
| Dec 28, 2024 | -43.20% |
| Sep 28, 2024 | 3.87% |
| Jun 29, 2024 | -57.39% |
| Mar 30, 2024 | -19.61% |
| Sep 30, 2023 | -0.68% |
| Jul 1, 2023 | 0.23% |
| Apr 1, 2023 | -8.12% |
| Dec 31, 2022 | 7.98% |
| Oct 1, 2022 | 0.47% |
| Jul 2, 2022 | 2.64% |
| Apr 2, 2022 | 7.97% |
| Jan 1, 2022 | 32.32% |
| Oct 2, 2021 | 11.08% |
| Jul 3, 2021 | 34.40% |